Patents Assigned to Regeneron
  • Il-17F-specific capture agents, compositions, and methods of using and making
    Patent number: 12517136
    Abstract: The present application provides stable peptide-based IL-17F capture agents and methods of use as detection agents. The application further provides methods of manufacturing IL-17F capture agents.
    Type: Grant
    Filed: March 23, 2020
    Date of Patent: January 6, 2026
    Assignees: California Institute of Technology, Regeneron
    Inventors: James R. Heath, Heather Agnew, Blake Farrow, David Bunck, Jingxin Liang, Arundhati Nag, Samir Das, Bert Tsunyin Lai, Suresh Mark Pitram